Tazeen Ahmad
Stock Analyst at Bank of America Securities
(4.11)
# 1,564
Out of 4,361 analysts
966
Total ratings
55.5%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics | Maintained: Sell | $8 → $3 | $3.14 | -4.46% | 23 | Jun 2, 2026 | |
| BCAX Bicara Therapeutics | Maintained: Buy | n/a | $19.64 | - | 4 | Jun 2, 2026 | |
| INCY Incyte | Maintained: Buy | $124 | $92.24 | +34.43% | 52 | Jun 1, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $125 | $89.14 | +40.23% | 53 | Jun 1, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $288 | $216.60 | +32.96% | 68 | May 29, 2026 | |
| APGE Apogee Therapeutics | Maintained: Buy | $131 | $78.77 | +66.31% | 5 | May 28, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,016 | $802.17 | +26.66% | 58 | May 26, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | n/a | $19.35 | - | 20 | May 22, 2026 | |
| FATE Fate Therapeutics | Reiterated: Hold | $2 → $2.2 | $2.57 | -14.40% | 12 | May 21, 2026 | |
| STRO Sutro Biopharma | Reiterated: Sell | n/a | $24.43 | - | 13 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $134.93 | - | 3 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $1.45 | +106.90% | 21 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $33 | $18.71 | +76.38% | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $84.35 | - | 41 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $860 | $602.92 | +42.64% | 11 | May 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $4 | $3.97 | +0.76% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $127.57 | - | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $68.23 | - | 49 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $31 → $33 | $28.98 | +13.87% | 18 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $9.19 | -12.95% | 16 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $44.68 | +29.81% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.26 | +52.09% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.89 | - | 45 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $304 → $307 | $328.26 | -6.48% | 4 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.34 | - | 35 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.78 | - | 46 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $26.94 | +18.78% | 14 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $286.12 | - | 45 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $154.84 | - | 46 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $598 | $425.09 | +40.68% | 23 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $8.00 | +75.00% | 22 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 → $110 | $71.29 | +54.30% | 14 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $27 | $8.31 | +224.91% | 19 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 | $16.25 | +16.92% | 69 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $700.60 | - | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $5.69 | +58.17% | 4 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.76 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $79 | $9.27 | n/a | 12 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $1 | $3.17 | n/a | 8 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.71 | n/a | 3 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 | $3.49 | n/a | 7 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $23 | $258.08 | n/a | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 → $1 | $23.19 | n/a | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $9 | $15.58 | n/a | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $8 | $2.39 | n/a | 6 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $45.64 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $1.05 | n/a | 1 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $1.95 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $18.23 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 → $48 | $22.25 | n/a | 3 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $41 → $6 | $7.37 | n/a | 2 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $8.11 | n/a | 1 | Feb 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $2.83 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $0.7091 | n/a | 1 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $71.20 | n/a | 1 | Jun 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $13 | $21.35 | n/a | 1 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $51.49 | n/a | 1 | Sep 19, 2014 |
Fulcrum Therapeutics
Jun 2, 2026
Maintained: Sell
Price Target: $8 → $3
Current: $3.14
Upside: -4.46%
Bicara Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $19.64
Upside: -
Incyte
Jun 1, 2026
Maintained: Buy
Price Target: $124
Current: $92.24
Upside: +34.43%
BioNTech SE
Jun 1, 2026
Maintained: Buy
Price Target: $125
Current: $89.14
Upside: +40.23%
Ascendis Pharma
May 29, 2026
Maintained: Buy
Price Target: $288
Current: $216.60
Upside: +32.96%
Apogee Therapeutics
May 28, 2026
Maintained: Buy
Price Target: $131
Current: $78.77
Upside: +66.31%
argenx SE
May 26, 2026
Maintained: Buy
Price Target: $1,016
Current: $802.17
Upside: +26.66%
Denali Therapeutics
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $19.35
Upside: -
Fate Therapeutics
May 21, 2026
Reiterated: Hold
Price Target: $2 → $2.2
Current: $2.57
Upside: -14.40%
Sutro Biopharma
May 21, 2026
Reiterated: Sell
Price Target: n/a
Current: $24.43
Upside: -
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $134.93
Upside: -
May 21, 2026
Reiterated: Sell
Price Target: $3
Current: $1.45
Upside: +106.90%
May 21, 2026
Reiterated: Buy
Price Target: $35 → $33
Current: $18.71
Upside: +76.38%
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $84.35
Upside: -
May 17, 2026
Maintained: Buy
Price Target: $860
Current: $602.92
Upside: +42.64%
May 15, 2026
Downgraded: Sell
Price Target: $18 → $4
Current: $3.97
Upside: +0.76%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $127.57
Upside: -
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $68.23
Upside: -
May 14, 2026
Maintained: Hold
Price Target: $31 → $33
Current: $28.98
Upside: +13.87%
May 8, 2026
Reiterated: Sell
Price Target: $8
Current: $9.19
Upside: -12.95%
May 8, 2026
Reiterated: Buy
Price Target: $58
Current: $44.68
Upside: +29.81%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $5.26
Upside: +52.09%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $20.89
Upside: -
May 1, 2026
Reiterated: Sell
Price Target: $304 → $307
Current: $328.26
Upside: -6.48%
Apr 16, 2026
Maintained: Buy
Price Target: n/a
Current: $8.34
Upside: -
Apr 16, 2026
Maintained: Buy
Price Target: n/a
Current: $21.78
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $32
Current: $26.94
Upside: +18.78%
Apr 15, 2026
Maintained: Buy
Price Target: n/a
Current: $286.12
Upside: -
Apr 15, 2026
Maintained: Buy
Price Target: n/a
Current: $154.84
Upside: -
Apr 15, 2026
Reiterated: Buy
Price Target: $598
Current: $425.09
Upside: +40.68%
Mar 18, 2026
Reiterated: Hold
Price Target: $14
Current: $8.00
Upside: +75.00%
Mar 3, 2026
Reiterated: Buy
Price Target: $112 → $110
Current: $71.29
Upside: +54.30%
Mar 2, 2026
Reiterated: Buy
Price Target: $24 → $27
Current: $8.31
Upside: +224.91%
Feb 25, 2026
Reiterated: Sell
Price Target: $19
Current: $16.25
Upside: +16.92%
Dec 18, 2025
Maintained: Buy
Price Target: n/a
Current: $700.60
Upside: -
Oct 16, 2025
Maintained: Buy
Price Target: $9
Current: $5.69
Upside: +58.17%
Apr 1, 2025
Downgraded: Sell
Price Target: $1
Current: $1.76
Upside: n/a
Sep 19, 2024
Maintained: Buy
Price Target: $82 → $79
Current: $9.27
Upside: n/a
Oct 17, 2023
Maintained: Sell
Price Target: $2 → $1
Current: $3.17
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $4
Current: $1.71
Upside: n/a
Mar 27, 2023
Maintained: Sell
Price Target: $6
Current: $3.49
Upside: n/a
Mar 6, 2023
Reiterated: Hold
Price Target: $4.5 → $23
Current: $258.08
Upside: n/a
Nov 16, 2022
Downgraded: Sell
Price Target: $5 → $1
Current: $23.19
Upside: n/a
Apr 19, 2022
Maintained: Sell
Price Target: $10 → $9
Current: $15.58
Upside: n/a
Jul 21, 2021
Maintained: Buy
Price Target: $16 → $8
Current: $2.39
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $150
Current: $45.64
Upside: n/a
Jun 3, 2019
Initiated Coverage: Hold
Price Target: $28
Current: $1.05
Upside: n/a
Mar 4, 2019
Initiated Coverage: Buy
Price Target: $26
Current: $1.95
Upside: n/a
Dec 20, 2018
Downgraded: Sell
Price Target: $8
Current: $18.23
Upside: n/a
Oct 10, 2018
Maintained: Hold
Price Target: $46 → $48
Current: $22.25
Upside: n/a
Aug 3, 2018
Downgraded: Sell
Price Target: $41 → $6
Current: $7.37
Upside: n/a
Feb 20, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $8.11
Upside: n/a
Nov 27, 2017
Initiated Coverage: Hold
Price Target: $16
Current: $2.83
Upside: n/a
Nov 8, 2016
Reiterated: Sell
Price Target: $5
Current: $0.7091
Upside: n/a
Jun 2, 2016
Reiterated: Sell
Price Target: $5
Current: $71.20
Upside: n/a
Sep 9, 2015
Downgraded: Sell
Price Target: $13
Current: $21.35
Upside: n/a
Sep 19, 2014
Reiterated: Buy
Price Target: $110
Current: $51.49
Upside: n/a